CorMedix Inc. (CRMD)
NASDAQ
Market Cap
$228.08M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
263 of 809
Rank in Industry
155 of 445
Largest Insider Buys in Sector
CRMD Stock Price History Chart
CRMD Stock Performance
About CorMedix Inc.
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
Insider Activity of CorMedix Inc.
Over the last 12 months, insiders at CorMedix Inc. have bought $112,068 and sold $0 worth of CorMedix Inc. stock.
On average, over the past 5 years, insiders at CorMedix Inc. have bought $295,910 and sold $55,394 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Todisco Joseph (Chief Executive Officer) — $175,636. DUNTON ALAN W (director) — $40,500. Mistry Erin (Chief Commercial Officer) — $4,000.
The last purchase of 13,561 shares for transaction amount of $50,718 was made by Todisco Joseph (Chief Executive Officer) on 2024‑03‑13.
List of Insider Buy and Sell Transactions, CorMedix Inc.
| 2024-03-13 | Todisco Joseph | Chief Executive Officer | 13,561 0.024% | $3.74 | $50,718 | +32.23% | ||
| 2023-12-15 | DUNTON ALAN W | director | 3,000 0.0055% | $3.30 | $9,900 | +20.92% | ||
| 2023-12-14 | DUNTON ALAN W | director | 3,000 0.0055% | $3.45 | $10,350 | +13.77% | ||
| 2023-11-17 | Mistry Erin | Chief Commercial Officer | 1,000 0.0018% | $4.00 | $4,000 | -5.11% | ||
| 2023-09-08 | Todisco Joseph | Chief Executive Officer | 10,000 0.0183% | $3.71 | $37,100 | -1.89% | ||
| 2023-05-18 | Kaplan Myron | director | 6,000 0.0139% | $4.54 | $27,258 | -14.19% | ||
| 2023-05-17 | Todisco Joseph | Chief Executive Officer | 5,000 0.0119% | $4.58 | $22,900 | -13.01% | ||
| 2023-05-17 | Stewart Robert A | director | 10,000 0.0227% | $4.37 | $43,735 | -13.01% | ||
| 2023-05-17 | Costa Paulo F | director | 10,000 0.0241% | $4.65 | $46,500 | -13.01% | ||
| 2023-05-17 | DUNTON ALAN W | director | 3,000 0.0067% | $4.33 | $12,980 | -13.01% | ||
| 2022-11-15 | Todisco Joseph | Chief Executive Officer | 20,000 0.0514% | $3.82 | $76,400 | +11.79% | ||
| 2022-08-24 | Todisco Joseph | Chief Executive Officer | 4,700 0.0114% | $3.92 | $18,424 | +4.58% | ||
| 2022-05-17 | Kaplan Myron | 5,000 0.0124% | $3.78 | $18,900 | +3.40% | |||
| 2022-05-16 | Todisco Joseph | Chief Executive Officer | 10,000 0.0235% | $3.38 | $33,800 | +8.86% | ||
| 2021-12-06 | David Matthew T | Interim CEO and CFO | 2,000 0.0052% | $4.50 | $9,000 | -13.93% | ||
| 2021-11-17 | David Matthew T | Interim CEO and CFO | 1,000 0.0027% | $5.07 | $5,070 | -20.71% | ||
| 2021-11-16 | Kaplan Myron | director | 10,000 0.0262% | $5.14 | $51,400 | -22.60% | ||
| 2021-05-21 | Sale | Masson-Hurlburt Elizabeth | EVP, Head of Clinical Ops | 8,000 0.0212% | $6.92 | $55,394 | -28.17% | |
| 2021-05-17 | Kaplan Myron | director | 15,000 0.0382% | $6.03 | $90,477 | -20.42% | ||
| 2020-09-04 | Lefkowitz Steven W | director | 5,715 0.0193% | $3.99 | $22,816 | +86.25% |
Insider Historical Profitability
12.22%
| Todisco Joseph | Chief Executive Officer | 352839 0.4009% | $4.15 | 6 | 0 | +1.12% |
| DUNTON ALAN W | director | 15250 0.0278% | $4.15 | 4 | 0 | +37.56% |
| Mistry Erin | Chief Commercial Officer | 4900 0.0089% | $4.15 | 1 | 0 | |
| Gelbfish Gary A. | director | 2101121 3.8333% | $4.15 | 2 | 0 | <0.0001% |
| PHARMABIO DEVELOPMENT INC | 10 percent owner | 778563 1.4204% | $4.15 | 0 | 1 | |
| TELLEZ CORA M | director | 182371 0.3327% | $4.15 | 15 | 0 | <0.0001% |
| Khan Mehmood | director | 178767 0.3261% | $4.15 | 10 | 0 | +14.8% |
| Kaplan Myron | director | 166034 0.3029% | $4.15 | 17 | 0 | +9.53% |
| ELLISON RUSSELL H | director | 160000 0.2919% | $4.15 | 1 | 0 | |
| ARMSTRONG JR. JOHN L. | Exec VP of Tech Operations | 96878 0.1767% | $4.15 | 5 | 0 | +6.01% |
| Baluch Khoso | Chief Executive Officer | 60905 0.1111% | $4.15 | 9 | 0 | +19.58% |
| Lefkowitz Steven W | director | 60498 0.1104% | $4.15 | 7 | 6 | +58.03% |
| MILBY RANDY | Chief Executive Officer | 57026 0.104% | $4.15 | 20 | 0 | +32.67% |
| Dillione Janet | director | 53473 0.0976% | $4.15 | 9 | 0 | <0.0001% |
| Houser Mark T. | Chief Medical Officer | 52832 0.0964% | $4.15 | 2 | 0 | |
| Lefkowitz James | director | 40272 0.0735% | $4.15 | 1 | 0 | |
| Markvicka Taunia | director | 37100 0.0677% | $4.15 | 3 | 0 | <0.0001% |
| Duffy Matthew | director | 28571 0.0521% | $4.15 | 0 | 2 | |
| Cook Robert W. | Chief Financial Officer | 27517 0.0502% | $4.15 | 6 | 0 | <0.0001% |
| Houghton John C. | President and CEO | 17328 0.0316% | $4.15 | 2 | 0 | |
| LENZ BRIAN | CFO, TREASURER & SECRETARY | 17000 0.031% | $4.15 | 3 | 0 | |
| Stewart Robert A | director | 11000 0.0201% | $4.15 | 1 | 0 | <0.0001% |
| Costa Paulo F | director | 10000 0.0182% | $4.15 | 1 | 0 | <0.0001% |
| GEORGE MICHAEL W | director | 10000 0.0182% | $4.15 | 3 | 0 | <0.0001% |
| HOFER TIMOTHY M | director | 8425 0.0154% | $4.15 | 1 | 0 | |
| Mounts Phoebe | General Counsel | 7200 0.0131% | $4.15 | 3 | 0 | +69.23% |
| David Matthew T | Interim CEO and CFO | 3150 0.0057% | $4.15 | 3 | 0 | +83.5% |
| Pfaffle Antony | Chief Scientific Officer | 0 0% | $4.15 | 1 | 19 | |
| Masson-Hurlburt Elizabeth | EVP, Head of Clinical Ops | 0 0% | $4.15 | 0 | 1 |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| BlackRock | $14.78M | 6.34 | 3.49M | -0.59% | -$87,772.24 | <0.0001 | |
| Nomura Holdings | $12.51M | 5.37 | 2.95M | +0.17% | +$20,720.88 | 0.11 | |
| The Vanguard Group | $12.42M | 5.33 | 2.93M | +3.64% | +$436,088.25 | <0.0001 | |
| Elliott Investment Management L P | $6.57M | 2.82 | 1.55M | 0% | +$0 | 0.07 | |
| Geode Capital Management | $5.02M | 2.15 | 1.18M | +2.1% | +$103,315.71 | <0.0001 | |
| State Street | $4.71M | 2.02 | 1.11M | +3.42% | +$155,709.76 | <0.0001 | |
| Northern Trust | $1.94M | 0.83 | 458,628 | +2.15% | +$41,009.29 | <0.0001 | |
| Renaissance Technologies | $1.01M | 0.43 | 238,659 | +1.25% | +$12,547.22 | <0.01 | |
| Susquehanna International Group | $872,855.00 | 0.37 | 205,862 | +10.96% | +$86,190.73 | <0.01 | |
| Morgan Stanley | $830,842.00 | 0.36 | 195,953 | -21.92% | -$233,285.16 | <0.0001 | |
| Barclays | $771,000.00 | 0.33 | 181,748 | -16.88% | -$156,526.39 | <0.0001 | |
| Spinnaker Capital LLC | $744,000.00 | 0.32 | 175,384 | 0% | +$0 | 100 | |
| Steward Partners Investment Advisory LLC | $669,551.00 | 0.29 | 157,913 | +14.42% | +$84,397.18 | 0.01 | |
| Bridgeway Capital Management | $638,968.00 | 0.27 | 150,700 | 0% | +$0 | 0.01 | |
| Nuveen | $634,643.00 | 0.27 | 149,680 | -38.02% | -$389,236.12 | <0.0001 | |
| Charles Schwab | $612,328.00 | 0.26 | 144,417 | -4.54% | -$29,158.48 | <0.0001 | |
| BNY Mellon | $564,868.00 | 0.24 | 133,224 | -18.71% | -$130,027.68 | <0.0001 | |
| D. E. Shaw & Co. | $548,533.00 | 0.24 | 129,371 | -9.71% | -$58,961.44 | <0.01 | |
| Citadel Advisors LLC | $492,998.00 | 0.21 | 116,273 | +186.6% | +$320,981.03 | <0.0001 | |
| Simplex Trading Llc | $405,000.00 | 0.17 | 95,540 | +227.35% | +$281,278.73 | 0.01 | |
| Raymond James Financial Services Advisors Inc | $353,171.00 | 0.15 | 83,295 | +1.78% | +$6,194.64 | <0.01 | |
| Wick Capital Partners Llc | $317,886.00 | 0.14 | 74,973 | -36.98% | -$186,560.28 | 0.34 | |
| Marshall Wace | $308,062.00 | 0.13 | 72,656 | -84.31% | -$1.66M | <0.0001 | |
| Two Sigma | $267,056.00 | 0.12 | 62,985 | -64.56% | -$486,551.99 | <0.0001 | |
| RhumbLine Advisers | $266,687.00 | 0.11 | 62,900 | -8.68% | -$25,362.82 | <0.0001 | |
| UBS | $262,464.00 | 0.11 | 61,902 | -3.84% | -$10,477.02 | <0.0001 | |
| LINSCO PRIVATE LEDGER CORP | $222,176.00 | 0.1 | 52,400 | +140.37% | +$129,744.00 | <0.0001 | |
| Planning Directions Inc | $212,000.00 | 0.09 | 50,000 | 0% | +$0 | 0.15 | |
| Raymond James Associates | $194,306.00 | 0.08 | 45,827 | +7% | +$12,719.97 | <0.0001 | |
| Wealth Enhancement Advisory Services LLC | $187,344.00 | 0.08 | 44,185 | +2.69% | +$4,905.67 | <0.01 | |
| Cibc Private Wealth Group Llc | $175,140.00 | 0.08 | 42,000 | 0% | +$0 | <0.0001 | |
| Goldman Sachs | $176,864.00 | 0.08 | 41,713 | +12.59% | +$19,771.22 | <0.0001 | |
| Lido Advisors, LLC | $156,999.00 | 0.07 | 37,028 | 0% | +$0 | <0.01 | |
| Invesco | $139,670.00 | 0.06 | 32,941 | +11.95% | +$14,907.86 | <0.0001 | |
| Private Advisor Group | $133,390.00 | 0.06 | 31,460 | 0% | +$0 | <0.01 | |
| Sigma Planning Corp | $132,814.00 | 0.06 | 31,324 | New | +$132,814.00 | <0.01 | |
| American Financial Advisors, LLC | $129,435.00 | 0.06 | 30,527 | 0% | +$0 | 0.02 | |
| Deutsche Bank | $121,379.00 | 0.05 | 28,627 | 0% | +$0 | <0.0001 | |
| Bank of America | $119,386.00 | 0.05 | 28,157 | -55.08% | -$146,377.91 | <0.0001 | |
| MetLife Investment Management | $113,861.00 | 0.05 | 26,854 | +13.28% | +$13,351.76 | <0.01 | |
| American International Group | $114,849.00 | 0.05 | 27,087 | -0.85% | -$983.68 | <0.0001 | |
| Group One Trading | $103,155.00 | 0.04 | 24,329 | -40.63% | -$70,604.51 | <0.01 | |
| Beacon Pointe Advisors Llc | $101,760.00 | 0.04 | 24,000 | 0% | +$0 | <0.01 | |
| AQR Capital | $101,039.00 | 0.04 | 23,830 | -32.6% | -$48,861.66 | <0.0001 | |
| JPMorgan Chase | $94,315.00 | 0.04 | 22,244 | -41.04% | -$65,639.75 | <0.0001 | |
| Dimensional Fund Advisors | $91,588.00 | 0.04 | 21,601 | 0% | +$0 | <0.0001 | |
| The Manufacturers Life Insurance Company | $86,878.00 | 0.04 | 20,490 | +1.78% | +$1,517.93 | <0.0001 | |
| Jane Street Capital | $85,033.00 | 0.04 | 20,055 | -68.47% | -$184,672.77 | <0.0001 | |
| Hightower Advisors | $81,000.00 | 0.04 | 19,138 | 0% | +$0 | <0.0001 | |
| Voya Investment Management LLC | $81,959.00 | 0.04 | 19,330 | -16.26% | -$15,912.68 | <0.0001 |